Filtered by:
US Ventures
We partner with ambitious entrepreneurs and support them as they scale. Meet our global portfolio, both past and present.

Filter by Sector

showing 104 results

Developing nausea treatments for surgical and cancer patients.

VISIT WEBSITE VISIT WEBSITE

Developing cost effective cytometers for laboratories. Acquired by Becton Dickinson.

VISIT WEBSITE VISIT WEBSITE

Dermatologist-led biopharmaceutical company.

VISIT WEBSITE VISIT WEBSITE

Gene therapy company.

VISIT WEBSITE VISIT WEBSITE

Developing the next generation of cancer immunotherapies.

VISIT WEBSITE VISIT WEBSITE

Cystoscopic technology for the treatment of overactive bladder.

VISIT WEBSITE VISIT WEBSITE

Developing novel therapeutic compounds to treat disease.

VISIT WEBSITE VISIT WEBSITE

Unlocking the power of benefits data.

VISIT WEBSITE VISIT WEBSITE

Biopharmaceutical company.

VISIT WEBSITE VISIT WEBSITE

Advancing therapies for the treatment of Idiopathic Pulmonary Fibrosis.

VISIT WEBSITE VISIT WEBSITE

Short-term rental and hospitality startup.

VISIT WEBSITE VISIT WEBSITE

Biotech company pioneering Antibody Oligonucleotide Conjugates.

VISIT WEBSITE VISIT WEBSITE

Re-platforming global capital markets.

VISIT WEBSITE VISIT WEBSITE

Biotechnology company.

VISIT WEBSITE VISIT WEBSITE

Life sciences R&D cloud platform.

VISIT WEBSITE VISIT WEBSITE

AI-powered platform for drug discovery.

VISIT WEBSITE VISIT WEBSITE

Developing novel therapies for diseases of the eye.

VISIT WEBSITE VISIT WEBSITE

Developing products for vascular and general surgeons.

VISIT WEBSITE VISIT WEBSITE

Developing personalised, highly-selective cancer therapies.

VISIT WEBSITE VISIT WEBSITE

Symptom and cure checker that uses an intelligent algorithm to diagnose patients.

VISIT WEBSITE VISIT WEBSITE

Developing lixivaptan, an oral compound for the potential treatment of hyponatremia.

VISIT WEBSITE VISIT WEBSITE

Gene editing company.

VISIT WEBSITE VISIT WEBSITE

Centivo is a new type of self-funded health plan built specifically for employers and their employees and families.  The Company targets zero healthcare trend and improved healthcare outcomes by rewar

VISIT WEBSITE VISIT WEBSITE

Developing approaches to activate the immune system to recognise and destroy tumour cells.

VISIT WEBSITE VISIT WEBSITE

Distributed NoSQL database-as-a-service for developers.

VISIT WEBSITE VISIT WEBSITE

Cloud-based platform helping software developers test and deploy their code.

VISIT WEBSITE VISIT WEBSITE

Developing and commercialising high-quality biosimilar therapeutics.

VISIT WEBSITE VISIT WEBSITE

Comprehensively drugging the tumor-immune synapse with human antibodies.

VISIT WEBSITE VISIT WEBSITE

Tech-enabled health insurance and clinical services solution.

VISIT WEBSITE VISIT WEBSITE

Develops AAV gene therapies for rare disease. Acquired by Ultragenyx Pharmaceuticals.

VISIT WEBSITE VISIT WEBSITE

A canine genomics and biotechnology company.

VISIT WEBSITE VISIT WEBSITE

Interest rate swaps trading venue.

VISIT WEBSITE VISIT WEBSITE

FinTech company connecting people with personalised financial products.

VISIT WEBSITE VISIT WEBSITE

Medical devices company.

VISIT WEBSITE VISIT WEBSITE

Primary care provider.

VISIT WEBSITE VISIT WEBSITE

Provider of high-ticket payment solutions.

VISIT WEBSITE VISIT WEBSITE